Home » Stocks » Bioanalytical Systems

Bioanalytical Systems, Inc. (BASI)

Stock Price: $5.19 USD 0.04 (0.78%)
Updated Aug 7, 2020 4:00 PM EDT - Market closed
After-hours: $5.90 +0.71 (13.68%) Aug 7, 7:58 PM

Stock Price Chart

Key Info

Market Cap 56.39M
Revenue (ttm) 54.58M
Net Income (ttm) -2.15M
Shares Out 10.86M
EPS (ttm) -0.21
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 7, 2020
Last Price $5.19
Previous Close $5.15
Change ($) 0.04
Change (%) 0.78%
Day's Open 5.01
Day's Range 5.01 - 5.23
Day's Volume 25,103
52-Week Range 2.00 - 6.50

More Stats

Market Cap 56.39M
Enterprise Value 89.83M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 10.86M
Float 7.11M
EPS (basic) -0.2
EPS (diluted) -0.21
FCF / Share -0.64
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 21,312
Short Ratio 1.31
Short % of Float 0.26%
Beta 1.48
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 1.03
PB Ratio 5.66
Revenue 54.58M
Operating Income -961,000
Net Income -2.15M
Free Cash Flow -6.93M
Net Cash -33.44M
Net Cash / Share -3.08
Gross Margin 23.67%
Operating Margin -1.76%
Profit Margin -3.90%
FCF Margin -12.70%
ROA -0.70%
ROE -21.27%
ROIC -2.10%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$2.15*
Low
2.15
Current: $5.19
High
2.15
Target: 2.15
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue43.6226.3524.2420.4422.7024.5822.0728.2133.1428.78
Revenue Growth65.55%8.68%18.59%-9.94%-7.67%11.4%-21.77%-14.89%15.16%-
Gross Profit12.928.127.704.437.497.967.066.8410.517.33
Operating Income-0.150.011.28-3.040.910.330.83-5.691.29-2.00
Net Income-0.79-0.190.88-3.231.10-1.070.77-6.322.30-2.69
Shares Outstanding10.388.778.188.118.087.967.667.165.674.92
Earnings Per Share-0.08-0.020.10-0.400.07-0.130.09-0.88-0.74-0.55
Operating Cash Flow1.783.491.241.062.101.681.59-0.201.092.44
Capital Expenditures-6.88-1.32-0.34-1.26-1.43-0.490.01-0.86-1.17-0.45
Free Cash Flow-5.102.170.90-0.200.671.191.61-1.06-0.091.99
Cash & Equivalents0.610.770.430.390.440.981.300.722.961.42
Total Debt16.639.584.585.344.846.027.418.369.6110.67
Net Cash / Debt-16.03-8.81-4.15-4.95-4.40-5.04-6.10-7.63-6.64-9.25
Assets41.9831.2720.4221.1323.8223.7725.6026.9832.3529.74
Liabilities31.2720.3811.9513.6713.0914.2416.1418.6018.0519.08
Book Value10.7110.888.477.4610.739.549.468.3814.3010.67
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Bioanalytical Systems, Inc.
Country United States
Employees 311
CEO Robert Leasure

Stock Information

Ticker Symbol BASI
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: BASI
IPO Date November 24, 1997

Description

Bioanalytical Systems, Inc., doing business as Inotiv, a pharmaceutical development company, provides drug discovery and development services, and analytical instruments for pharmaceutical, biotechnology, academic, and government organizations in the United States, rest of North America, the Pacific Rim, Europe, and internationally. It operates through two segments, Contract Research Services and Research Products. The Contract Research Services segment offers screening and pharmacological testing, nonclinical safety testing, formulation development, regulatory compliance, and quality control testing services. This segment also provides in vivo sampling services for the continuous monitoring of chemical changes in life; non-clinical toxicology and pathology services; analytical method development and validation; drug metabolism, bioanalysis, and pharmacokinetics testing to measure drug and metabolite concentrations in complex biological matrices; stability testing to ensure the integrity of various solutions used in nonclinical and clinical studies, and post-study analyses; and climate-controlled archiving services for its customers' data and samples. The Research Products segment offers analytical products comprising liquid chromatographic and electrochemical instruments with associated accessories; in vivo sampling products consisting of Culex family of automated in vivo sampling and dosing instruments; and Vetronics' products, such as instruments and related software to monitor and diagnose cardiac function, and measure other vital physiological parameters in cats and dogs in veterinary clinics. Bioanalytical Systems, Inc. was founded in 1974 and is headquartered in West Lafayette, Indiana.